ARTICLE | Clinical News
Restasis cyclosporine regulatory update
December 6, 2010 8:00 AM UTC
Allergan said Health Canada approved Restasis 0.05% cyclosporine ophthalmic emulsion to treat moderate to moderately severe dry eye disease. Restasis is already approved in the U.S. to increase tear p...